The News London 365
  • Breaking News
  • Lifestyle
  • Coronavirus
  • Food
  • Politics
  • Sport
Sunday, June 26, 2022
London
+10°C
Privacy Policy
Copyright
Contact us
No Result
View All Result
  • Breaking News
  • Lifestyle
  • Coronavirus
  • Food
  • Politics
  • Sport
No Result
View All Result
The News London 365
No Result
View All Result
Home Coronavirus

Moderna says COVID-19 vaccine supply outside United States to slow down By Reuters

The News London 365 by The News London 365
July 27, 2021
in Coronavirus
0
More than half of Australia's population under COVID-19 lockdowns By Reuters

© Reuters. FILE PHOTO: Test tubes are seen in front of a displayed Moderna logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration/File Photo

By Sangmi Cha

SEOUL (Reuters) – Moderna (NASDAQ:) said on Tuesday its COVID-19 vaccine manufacturing partners outside the United States are facing delays due to laboratory testing operations that have occurred in the past few days, slowing the supply of the shot to these markets.

The vaccine maker’s comments come after South Korean health officials said earlier in the day that Moderna has delayed its late-July vaccine shipment schedule for the country to August due to supply problems.

“We are currently not reserving safety stock to allow vaccines to be delivered faster, which means that we do not have stock in storage to smooth these types of shortfalls or delays,” a Moderna spokesperson said. The issue was now resolved, but the delay will lead to a short-term adjustment in the upcoming 2-4 weeks, the spokesperson said.

The shipment delay comes as the South Korean government expands its inoculation campaign to people in their 50s and workers in its vital computer chip and electronic sector.

The disruption has forced authorities to switch to the Pfizer (NYSE:) vaccine for some vaccinations.

Moderna and its manufacturing partners are working to minimize this shortfall across all impacted nations, the company said without naming the affected countries and the severity of the issue.

The supply issue is linked to the vaccine manufacturing process involving Swiss contract drugmaker Lonza and a Spain-based company, which does bottling work for the Moderna vaccine, said Jung Eun-young, head of the vaccine procurement team.

“This means the production-related issue does not only affect South Korea. Rather it is a common problem for countries that receive the volume from the manufacturing site,” Jung said in a news conference.

She did not name the Spanish firm, but contract drugmaker Rovi bottles, or “fills and finishes,” Moderna vaccines for markets other than the United States.

Contract drugmaker Lonza said questions on COVID-19 vaccine should be directed to Moderna. Rovi was not available for comment.

South Korea has a contract for 40 million doses of the Moderna vaccine, of which about 1.1 million have already arrived.

The country is battling a fourth wave of infections linked to the spread of the more contagious Delta variant and public complacency that has seen daily cases breach the 1,000 mark for the first time since December.

Authorities reported 1,365 new coronavirus cases for Monday.

South Korean officials said the Moderna vaccines scheduled to arrive in August remained on schedule, adding that a detailed shipment plan would be made public once finalised.

Shares of the drugmaker fell 3.7% to $323.5 in morning trade.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Previous Post

COVID-19: Data shows vaccines reduce risk of hospitalisation and death – but you need to read it with a clear head | UK News

Next Post

BBC Olympics: The famous singer who Jeanette Kwakye counts as her best friend

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECENT NEWS

Canada to send 8 armoured vehicles to Ukraine amid heavy weapons push

Canada to send 8 armoured vehicles to Ukraine amid heavy weapons push

June 26, 2022
My OCD makes me think I’m going to kill someone or be killed

My OCD makes me think I’m going to kill someone or be killed

June 26, 2022
Embracing quiet moments can change your life for the better – here’s how

Embracing quiet moments can change your life for the better – here’s how

June 26, 2022
The Big Happiness Interview: Sonia Choquette on why your intuition is your superpower

The Big Happiness Interview: Sonia Choquette on why your intuition is your superpower

June 26, 2022
I was told to wear a black bra to cure my breast cancer – these kinds of suggestions are dangerous

I was told to wear a black bra to cure my breast cancer – these kinds of suggestions are dangerous

June 26, 2022
£33m cash boost would ‘give us truly global appeal’

£33m cash boost would ‘give us truly global appeal’

June 26, 2022

Categories

Breaking News Coronavirus Daily Devotionals Food Health and Science Lifestyle Politics Sport What's On

Recent News

Canada to send 8 armoured vehicles to Ukraine amid heavy weapons push

Canada to send 8 armoured vehicles to Ukraine amid heavy weapons push

June 26, 2022
The News London 365

  • Privacy Policy
  • Copyright
  • Contact us
No Result
View All Result
  • Breaking News
  • Lifestyle
  • Coronavirus
  • Food
  • Politics
  • Sport

© 2022 JNews - Premium WordPress news & magazine theme by Jegtheme.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT